Objectives The aim of this study was to systematically collate and appraise the available
evidence regarding the associations between small, dense low-density lipoprotein (sdLDL) …

A direct and an indirect relationship between paraoxonase 1 (PON1) and atherosclerosis
exists. Given PON1's physical location within high‐density lipoprotein (HDL) particles and its …

OBJECTIVE: Small, dense low-density lipoprotein (sdLDL) and small-sized high-density
lipoprotein (HDL) particles are established risk factors for ischemic heart disease. However …

The presence of residual cardiovascular disease (CVD) risk is a current dilemma in clinical
practice; indeed, despite optimal management and treatment, a considerable proportion of …

Colorectal cancer (CRC) is a highly prevalent malignancy with multifactorial etiology, which
includes metabolic alterations as contributors to disease development. Studies have shown …

Lipoproteins modulate innate and adaptive immune responses. In the chronic inflammatory
disease multiple sclerosis (MS), reports on lipoprotein level alterations are inconsistent and …

Dyslipidaemia plays a prominent role in the genesis of atherosclerotic plaque and the
increased cardiovascular risk in diabetes. Macrophages readily take up atherogenic …

Pregnancy is associated with alterations in low-density lipoprotein (LDL) and high-density
lipoprotein (HDL) subclasses, but the exact pattern of these variations remains controversial …

Elevated serum uric acid (UA) is associated with higher risk for cardiovascular disease
(CVD). Smaller, denser low density lipoprotein (LDL) and high-density lipoprotein (HDL) …

Compelling evidence supports the causative link between increased levels of low-density
lipoprotein cholesterol (LDL-C) and atherosclerotic cardiovascular disease (CVD) …